ERBB2 and breast carcinoma: The eligibility criteria were low-risk stage I breast cancer, which means pathologically proven invasive ductal carcinoma, Union for International Cancer Control (UICC) T1N0M0, age 60 years and over, estrogen receptor positive, no extensive lymphatic vessel invasion (LVSI), no extensive intraductal component (EIC), and human epidermal growth factor receptor 2 (HER2) negative [9].